Dublin, Jan. 08, 2020 (GLOBE NEWSWIRE) -- The "Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)" report has been added to ResearchAndMarkets.com's offering.

The Global In Vitro Diagnostics Market was valued at USD 61,700.22 Million in the year 2018.

As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised treatment and drugs are administered to the patient specifically.

Additionally, number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyle, air and water pollution, genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.

Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained.

By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.

Scope of the Report

Global In Vitro Diagnostics Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

• In Vitro Diagnostics Market - Size, Growth, Forecast
• Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
• Analysis By Application: Infectious Disease, Non Infectious Disease
• Analysis By End User: Hospital, Laboratory, Home Test, Others
• Analysis By Product - Medical Devices, Reagents & Kits, Services

Regional Analysis - North America, Latin America, Asia Pacific, EMEA (Actual Period: 2014-2018, Forecast Period: 2019-2024)

• In Vitro Diagnostics Market - Size, Growth, Forecast
• Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
• Analysis By Application: Infectious Disease, Non Infectious Disease
• Analysis By End User: Hospital, Laboratory, Home Test, Others
• Analysis By Product - Medical Devices, Reagents & Kits, Services

Country Analysis - USA, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)

• In Vitro Diagnostics Market - Size, Growth, Forecast
• Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
• Analysis By Application: Infectious Disease, Non Infectious Disease
• Analysis By End User: Hospital, Laboratory, Home Test, Others
• Analysis By Product - Medical Devices, Reagents & Kits, Services

Other Report Highlights

• Competitive Landscape
• Leading Companies
• Key Developments
• Market Dynamics - Drivers and Restraints
• Market Trends
• SWOT Analysis

Companies Profiled

• Roche
• Sysmex
• Abbott
• Danaher
• Siemens Healthineers
• bioMerieux
• Becton-Dickinson
• Thermofisher Scientific
• Bio-Rad
• Ortho clinical Diagnostics

Strategic Recommendations

• Focus on Theranostics
• Investment in Microbiology System Automation
• Reducing the Cost of Diagnostic Test

For more information about this report visit https://www.researchandmarkets.com/r/2d7z9f

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.